Estrada, Irene .

HRN: 17-94-03  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/06/2025
CEFUROXIME 1.5GM (VIAL)
07/06/2025
07/12/2025
IV
1.5g
Qq
Tonsillitis
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: